NSW Health and UTS Science Partnership PhD Scholarship
$40,000 p/a for 3 years.
This scholarship stipend is $40,000 p/a for 3 years (or part time equivalent, pro-rata). The stipend is to assist the PhD candidate with general living costs.
A unique opportunity exists to apply for a PhD Scholarship to work with within one of the best respiratory groups worldwide (respiratoryresearchgroup.org) and the leading respiratory medtech company within Australia, Pharmaxis (www.pharmaxis.com.au).
New drugs are needed for asthma and COPD. These diseases affect around 3 million Australians. Not only are they a considerable source of morbidity and mortality, the economic costs are substantial comprising $1.5 billion of annual direct costs to the public health system.
In this PhD project you will work in labs in both institutions, and importnantly be mentored by leading academics and industry people. You will contribute to the preclinical development program of novel therapeutics developed by both Pharmaxis and the Respiratory Research Group. You will use cutting edge in-vitro and in-vivo models and the latest analytical techniques (eg RNAseq, proteomics, superhigh resolution microscopy)
Ultimately, your PhD will train you in all aspects of commercial preclinical drug development. This is an area of growth within Australia, as most pharmaceutical R&D is currently based overseas.
Who is eligible?
- Candidates must meet all of the following criteria:
- Candidates must be an Australian citizen or permanent resident. Candidates on any form of temporary visa will not be deemed eligible.
- Candidates must hold an undergraduate degree with at least a credit average (or equivalent).
- Candidates must also have research experience through an Honours program (first class or second class, division one) or Master’s degree by research in a relevant subject. Candidates with a Master’s degree by coursework will not be deemed eligible.
- Aboriginal and Torres Strait Islander researchers, people from culturally and linguistically diverse backgrounds, and primary carers who have experienced career disruptions, are encouraged to apply.
- Candidates must be available to commence in the Spring 2020 semester by 25 August 2020.
It is essential that you have an honours or masters degree in which you have experience with in-vivo models (of any disease). Cell and tissue analysis techniques are desirable, but we will train you in any techniques that you are not proficient in.
Need more information? Contact...
Please contact Professor Brian Oliver